US 6624166
Pyridazines as interleukin-1&bgr; converting enzyme inhibitors
expired A61PA61P19/02A61P29/00
Quick answer
US patent 6624166 (Pyridazines as interleukin-1&bgr; converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P19/02, A61P29/00, A61P35/00, A61P43/00